148 related articles for article (PubMed ID: 27102843)
1. Prophylactic irradiation of para-aortic lymph nodes for patients with locally advanced cervical cancers with and without high CA9 expression (KROG 07-01): A randomized, open-label, multicenter, phase 2 trial.
Kim JH; Kim JY; Yoon MS; Kim YS; Lee JH; Kim HJ; Kim H; Kim YJ; Yoo CW; Nam BH; Kim TH; Kim SK; Kim SH; Kang S; Seo SS; Lim MC; Park SY
Radiother Oncol; 2016 Sep; 120(3):383-389. PubMed ID: 27102843
[TBL] [Abstract][Full Text] [Related]
2. Randomized multicenter phase II trial of prophylactic irradiation of para-aortic lymph nodes in advanced cervical cancer according to tumor hypoxia: Korean Radiation Oncology Group (KROG 07-01) study.
Yoon M; Lee HK; Park EY; Kim JH; Lee JH; Kim YS; Kim HJ; Kim H; Yoo CW; Lee S; Hong EK; Kim TH; Kim TS; Seo SS; Kang S; Chang SJ; Shin HJ; Uong TNT; Lee S; Kim JY
Int J Cancer; 2022 Dec; 151(12):2182-2194. PubMed ID: 35751421
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience.
Lee J; Lin JB; Chang CL; Jan YT; Sun FJ; Wu MH; Chen YJ
Gynecol Oncol; 2017 Jul; 146(1):20-26. PubMed ID: 28457584
[TBL] [Abstract][Full Text] [Related]
4. The role of elective para-aortic lymph node irradiation in patients with locally advanced cervical cancer.
Yap ML; Cuartero J; Yan J; Pintilie M; Fyles A; Levin W; Manchul L; Milosevic M
Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):797-803. PubMed ID: 25194726
[TBL] [Abstract][Full Text] [Related]
5. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.
Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919
[TBL] [Abstract][Full Text] [Related]
7. Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer.
Lee S; Shin HJ; Han IO; Hong EK; Park SY; Roh JW; Shin KH; Kim TH; Kim JY
Cancer Sci; 2007 Mar; 98(3):329-33. PubMed ID: 17233814
[TBL] [Abstract][Full Text] [Related]
8. Does postoperative prophylactic irradiation of para-aortic lymph nodes reduce the risk of recurrence in uterine cervical cancer with positive pelvic lymph nodes?
Yoshida K; Kajiyama H; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Utsumi F; Niimi K; Suzuki S; Kikkawa F
Int J Clin Oncol; 2019 May; 24(5):567-574. PubMed ID: 30612268
[TBL] [Abstract][Full Text] [Related]
9. Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes.
Lee J; Lin JB; Chang CL; Sun FJ; Wu MH; Jan YT; Chen YJ
Gynecol Oncol; 2018 Feb; 148(2):291-298. PubMed ID: 29269219
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer.
Kim JY; Shin HJ; Kim TH; Cho KH; Shin KH; Kim BK; Roh JW; Lee S; Park SY; Hwang YJ; Han IO
J Cancer Res Clin Oncol; 2006 May; 132(5):302-8. PubMed ID: 16416108
[TBL] [Abstract][Full Text] [Related]
12. Escalated radiation and prophylactic extended field nodal irradiation are beneficial for FIGO IIIB cervical cancer patients' prognosis.
Meng Q; Wang W; Liu X; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
Radiat Oncol; 2018 Nov; 13(1):223. PubMed ID: 30453993
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic extended-field irradiation for locally advanced cervical cancer.
Li H; Wang S; Liu Y; Wang T; Jin S; Liu Z
Gynecol Oncol; 2022 Sep; 166(3):606-613. PubMed ID: 35868881
[TBL] [Abstract][Full Text] [Related]
14. Is Prophylactic Irradiation to Para-aortic Lymph Nodes in Locally Advanced Cervical Cancer Necessary?
Park SG; Kim JH; Oh YK; Byun SJ; Kim MY; Kwon SH; Kim OB
Cancer Res Treat; 2014 Oct; 46(4):374-82. PubMed ID: 25043821
[TBL] [Abstract][Full Text] [Related]
15. Para-aortic lymph node metastases in locally advanced cervical cancer: Comparison between surgical staging and imaging.
Vandeperre A; Van Limbergen E; Leunen K; Moerman P; Amant F; Vergote I
Gynecol Oncol; 2015 Aug; 138(2):299-303. PubMed ID: 26007204
[TBL] [Abstract][Full Text] [Related]
16. Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
Ramlov A; Kroon PS; Jürgenliemk-Schulz IM; De Leeuw AA; Gormsen LC; Fokdal LU; Tanderup K; Lindegaard JC
Acta Oncol; 2015; 54(9):1567-73. PubMed ID: 26271799
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Extended-Field Irradiation Versus Pelvic Irradiation in Patients With Cervical Cancer With 2018 FIGO Stage IIIC1 Disease.
Wang W; Meng Q; Zhou Y; Hu K; Zhang F; Qiu J; Hou X; Lian X; Yan J; Liu Z; Sun S; Ma J; Liu X
Pract Radiat Oncol; 2023; 13(5):e409-e415. PubMed ID: 37075837
[TBL] [Abstract][Full Text] [Related]
18. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Extended-Field Irradiation in Patients With Cervical Cancer: A Literature Review.
Wang W; Zhou Y; Wang D; Hu K; Zhang F
Front Oncol; 2020; 10():579410. PubMed ID: 33123482
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
Tsai CS; Lai CH; Chang TC; Yen TC; Ng KK; Hsueh S; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):477-84. PubMed ID: 19464824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
